Multiple Choice
A 72-year-old man with a history of Parkinson disease comes to the office for follow-up. The patient has been taking levodopa/carbidopa since being diagnosed 5 years ago, and has required increasing doses of medication to control his symptoms. He is currently on a maximum dose, but for the past several months has experienced bothersome motor fluctuations. The patient also reports worsening stiffness and difficulty moving before his next scheduled dose, which improves after taking the medication. Entacapone is added to his treatment regimen. This drug most likely improves this patient's symptoms by which of the following mechanisms?
A) Decreasing peripheral levodopa degradation
B) Directly stimulating dopamine receptors
C) Enhancing the effect of endogenous dopamine
D) Inhibiting central muscarinic receptors
E) Inhibiting centrally-active acetylcholinesterase
Correct Answer:

Verified
Correct Answer:
Verified
Q434: A 57-year-old woman comes to the office
Q435: A 32-year-old woman comes to the physician
Q436: A 17-year-old girl is brought to the
Q437: A 64-year-old man comes to the office
Q438: A 46-year-old man comes to the office
Q440: A 34-year-old man diagnosed with advanced non-Hodgkin
Q441: A 50-year-old man has recurrent episodes of
Q442: An 82-year-old woman is brought to the
Q443: A 46-year-old woman with confusion and fever
Q444: A 60-year-old man comes to the office